BG104865A - Paroxetinne-containing compositions - Google Patents

Paroxetinne-containing compositions

Info

Publication number
BG104865A
BG104865A BG104865A BG10486500A BG104865A BG 104865 A BG104865 A BG 104865A BG 104865 A BG104865 A BG 104865A BG 10486500 A BG10486500 A BG 10486500A BG 104865 A BG104865 A BG 104865A
Authority
BG
Bulgaria
Prior art keywords
paroxetinne
containing compositions
paroxetine
adsorbed
therapy
Prior art date
Application number
BG104865A
Other languages
Bulgarian (bg)
Inventor
Andrew Craig
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG104865A publication Critical patent/BG104865A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Paroxetine is adsorbed on a carrier to form a free-flowing powder useful for capsule filling or for tablet formation; and used in therapy to treat depression. 9 claims
BG104865A 1998-03-24 2000-10-16 Paroxetinne-containing compositions BG104865A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (1)

Publication Number Publication Date
BG104865A true BG104865A (en) 2001-05-31

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104865A BG104865A (en) 1998-03-24 2000-10-16 Paroxetinne-containing compositions

Country Status (20)

Country Link
EP (1) EP1063993A1 (en)
JP (1) JP2002507569A (en)
CN (1) CN1125639C (en)
AP (1) AP2000001914A0 (en)
AU (1) AU754765B2 (en)
BG (1) BG104865A (en)
BR (1) BR9908991A (en)
CA (1) CA2324612A1 (en)
EA (1) EA003393B1 (en)
GB (1) GB9806312D0 (en)
HU (1) HUP0101326A3 (en)
ID (1) ID26485A (en)
IL (1) IL138478A0 (en)
NO (1) NO313404B1 (en)
NZ (1) NZ506893A (en)
PL (1) PL343095A1 (en)
SK (1) SK14102000A3 (en)
TR (1) TR200002750T2 (en)
WO (1) WO1999048499A1 (en)
ZA (1) ZA200005697B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
CA2531097C (en) * 2003-07-02 2012-10-09 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (en) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 Paroxetine mesylate capsule and preparation method thereof
CN104027306A (en) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 Paroxetine oral suspension and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
SK283608B6 (en) * 1995-02-06 2003-10-07 Smithkline Beecham Plc New forms of parotexin hydrochloride
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
EA200000977A1 (en) 2001-02-26
CA2324612A1 (en) 1999-09-30
SK14102000A3 (en) 2001-03-12
NO20004740D0 (en) 2000-09-22
NO20004740L (en) 2000-10-03
JP2002507569A (en) 2002-03-12
EA003393B1 (en) 2003-04-24
CN1294512A (en) 2001-05-09
CN1125639C (en) 2003-10-29
PL343095A1 (en) 2001-07-30
ID26485A (en) 2001-01-11
NZ506893A (en) 2003-06-30
TR200002750T2 (en) 2000-12-21
GB9806312D0 (en) 1998-05-20
AU754765B2 (en) 2002-11-21
HUP0101326A3 (en) 2002-06-28
BR9908991A (en) 2000-12-12
AP2000001914A0 (en) 2000-09-30
WO1999048499A1 (en) 1999-09-30
IL138478A0 (en) 2001-10-31
EP1063993A1 (en) 2001-01-03
ZA200005697B (en) 2001-10-02
HUP0101326A2 (en) 2002-05-29
AU3045199A (en) 1999-10-18
NO313404B1 (en) 2002-09-30

Similar Documents

Publication Publication Date Title
EP0818991A4 (en) Controlled release insufflation carrier for medicaments
MY121397A (en) Ziprasidone formulations
MX9700223A (en) Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension.
IL110045A (en) Pharmaceutical compositions containing oligopeptides for combating AIDS and ARC and for immune stimulation and certain such novel oligopeptides
HUT75648A (en) 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and pharmaceutical compositions containing them
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
CA2284663A1 (en) Rapidly dissolving robust dosage form
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
MY128809A (en) Pharmaceutical formulation of omeprazole
EP1004310A4 (en) Gelled composition
HUP0101568A3 (en) Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes, pharmaceutical compositions containing them and process for producing them
GB2367004B (en) A cyclosporin containing composition in the form of a capsule
NZ336592A (en) Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier
BG104865A (en) Paroxetinne-containing compositions
MY106371A (en) Oral pharmaceutical compositions in unit dosage form
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
NZ504418A (en) Delayed release oral dosage form of carvedilol
MY115533A (en) Benzothiophenes, formulation containing same and methods
ES8707488A1 (en) Biologically active ketone derivative, preparation and use.
MX9709838A (en) Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions.
HK1056315A1 (en) Use of bifidobacteria in manufacture of medicaments for preventing diarrhea.
MD970269A (en) Clavulanates
HUT49320A (en) Process for producing ornithine derivatives and pharmaceutical compositions containing them as active components
GB2218711B (en) Process for producing powdered inorganic compounds and metal compositions.
HU9402648D0 (en) 3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine composition containing them as active componens